Rentschler Biopharma SE
We are a leading global Contract Development and Manufacturing Organization (CDMO), focused exclusively on client projects. From our headquarters in Laupheim, Germany, and our site in Milford, MA, USA, we offer end-to-end solutions including biopharmaceutical process development and manufacturing as well as related consulting activities such as project management and regulatory support. Thanks to our 50 years of proven scientific expertise in biotechnology and our passion for what we do, we count ourselves among the leaders in the industry and make an essential contribution to the global availability of biopharmaceuticals.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Globally (various continents)
- Year Founded:
- 1872
This company also provides solutions for other industrial applications.
Please, visit the following links for more info:
About Us
As a biotechnology pioneer, Rentschler Biopharma built a reputation through the early development of different interferon products (Fiblaferon, Polyferon).
We, at Rentschler Biopharma, empower our clients to help patients with serious or rare diseases.
With our dedication and expertise, we convert medical research into outstanding biopharmaceuticals.
We are a leading contract development and manufacturing organization (CDMO), offering process development and manufacturing of biopharmaceuticals as well as related consulting activities, including project management and regulatory support.
We make a significant contribution to biopharmaceutical production, thereby meeting the needs of emerging therapies and helping millions of people each day. We are among the best in the industry and set new standards in client focus, individual customized solutions and reliability.
This is precisely what we stand for, and we are proud of it. Within just a few years, we have become an international CDMO in our field. Our conviction drives our performance both in the present and future.
We seek to partner with our clients to exceed expectations and develop effective solutions, even for the most complex products and processes. Our client partners benefit from our continual investment in high-end technologies that increase efficiency and productivity to reduce time-to-clinic and market.
We are more than just a CDMO: We serve as a consultant, advising our clients and advocating for solutions that guarantee project success.
Facts and Figures
- Independent, family-owned company in 5th generation
- Chairman of the supervisory board is Prof. Dr. Nikolaus F. Rentschler
- Headquartered in Laupheim, Germany
- Site in Milford, MA, USA
- Rentschler ATMP Ltd. in Stevenage, UK, focused on cell and gene therapies
- Gross area: more than 43,000 m²
- Biotechnology Pioneer
- Full-service solutions, addressing clinical and commercial needs
- Contract development and manufacturing of biopharmaceuticals in mammalian cell culture
- We are the outsourcing partner for more than 150 clients worldwide
- We work with small and big biotech companies as well as big pharma
- Our clients include 17 of the world’s top 20 pharma companies
- We work with approx. 40% of our clients for more than 5 years
- Approx. 50% of our clients work with us on more than one project
- 50 years of experience in process development and manufacturing of biopharmaceuticals
- Expertise with over 300 different molecules and over 110 different therapeutic protein formats
- Deep understanding of international regulatory requirements, incl. special regulatory pathways (e.g. orphan drugs, biosimilars)
- 49 international inspections in Laupheim, DE, since 2000
- 2 FDA & 5 inspections of other authorities completed with zero findings in the last 3 years